These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 4625832)

  • 1. Diagnostic Use of Chelating Agents.
    Jennrich P
    Dtsch Arztebl Int; 2017 Apr; 114(14):252-253. PubMed ID: 28446358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. A. The oligo-elements].
    Le Jeune JR
    Bull Soc Belge Ophtalmol; 1972; 160(1):241-54. PubMed ID: 4537987
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible side-effects of antidotal therapy].
    Wirth W
    Arch Toxikol; 1968; 24(1):71-82. PubMed ID: 4974058
    [No Abstract]   [Full Text] [Related]  

  • 4. [Harmful effects of common drugs on the visual apparatus. Anti-infective drugs. C. Fungistatic agents].
    Dralands L
    Bull Soc Belge Ophtalmol; 1972; 160(1):422-4. PubMed ID: 5065368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Harmful effects of common drugs on the visual apparatus. Anti-infective drugs. D. Antiprotozoal agents].
    Dralands L
    Bull Soc Belge Ophtalmol; 1972; 160(1):424-6. PubMed ID: 5047222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. B. Chelating agents].
    van Oye R
    Bull Soc Belge Ophtalmol; 1972; 160(1):255-7. PubMed ID: 4625832
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical uses of metal-binding drugs.
    Chenoweth MB
    Clin Pharmacol Ther; 1968; 9(3):365-87. PubMed ID: 4984845
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical usefulness of iron chelating agents.
    Waxman HS; Brown EB
    Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246
    [No Abstract]   [Full Text] [Related]  

  • 9. [D-penicillamine nephropathy].
    Ohno I
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):523-5. PubMed ID: 9277805
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic chelating agents.
    Jones MM; Pratt TH
    J Chem Educ; 1976 Jun; 53(6):342-7. PubMed ID: 818097
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of aluminium-chelating compounds for clinical use.
    Domingo JL
    Adverse Drug React Toxicol Rev; 1996 Aug; 15(3):145-65. PubMed ID: 8931775
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.